Salarius Pharmaceuticals (SLRX)

• Market cap: $5.51M
• 1 day: 1.62%
• 5 days: 21.12%
• 1 month: -74.8%
• 3 months: -83.45%
• 6 months: -92.17%
• Year to date: -96.4%
• 1 year: -95.62%
• 5 years: -99.95%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Employees: 2